Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




New Genetic Loci Link to Insufficient and Excessive Sleep Duration

By LabMedica International staff writers
Posted on 18 Mar 2019
Genetic loci have been found that are linked to either abnormally long or short sleep duration.

Despite sleep being an essential state of decreased activity and alertness - with both insufficient sleep and excessive sleep being linked to significant health problems - molecular factors regulating sleep duration remain unknown.

In this regard, investigators at Massachusetts General Hospital (Boston, USA) and the University of Exeter Medical School (United Kingdom) conducted an extensive genome wide analysis study (GWAS) to address sleep duration. More...
The investigators analyzed genetic data from more than 446,000 participants in the U.K. Biobank who self-reported the amount of sleep they typically received.

The study identified 78 loci (76 previously unknown) for self-reported habitual sleep duration. The 78 loci further associated with accelerometer-derived sleep duration, daytime inactivity, sleep efficiency, and number of sleep bouts in secondary analysis of 85,499 individuals. Loci were enriched for pathways including striatum and subpallium development, mechanosensory response, dopamine binding, synaptic neurotransmission, and plasticity, among others.

Short sleep duration was genetically linked with traits such as insomnia and smoking, while long-duration variants were linked with schizophrenia, type II diabetes, and coronary artery disease.

"While we spend about a third of our life asleep, we have little knowledge of the specific genes and pathways that regulate the amount of sleep people get," said first author Dr. Hassan Saeed Dashti, a research fellow at Massachusetts General Hospital. "Our study suggests that many of the genes important for sleep in animal models may also influence sleep in humans and opens the door to better understanding of the function and regulation of sleep."

The study was published in the March 7, 2019, online edition of the journal Nature Communications.

Related Links:
Massachusetts General Hospital
University of Exeter Medical School


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
New
DNA/RNA Extraction/Purification Kit
Nucleic Acid Extraction or Purification Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.